Impact of abdominal or pelvic radiotherapy on disease activity in inflammatory bowel disease: a multicentre cohort study from the GETAID

Broussard D, Rivière P, Bonnet J, Fotsing G, Amiot A, Peyrin-Biroulet L, Rajca S, Buisson A, Gilleta C, Pelletier AL, Serrero M, Bouguen G, Altwegg R, Hebuterne X, Nancey S, Fumery M, Cadiot G, Nahon S, Rahier JF, Gornet JM, Vendrely V, Laharie D; Groupe d’Étude Thérapeutique des Affections Inflammatoires du Tube Digestif (GETAID)

Published Feb 2021, in the Alimentary pharmacology & therapeutics

Impact of the COVID-19 outbreak and the serum prevalence of SARS-CoV-2 antibodies in patients with inflammatory bowel disease treated with biologic drugs

Bossa F, Carparelli S, Latiano A, Palmieri O, Tavano F, Panza A, Pastore M, Marseglia A, D'Altilia M, Latiano T, Corritore G, Martino G, Nardella M, Guerra M, Terracciano F, Sacco M, Perri F, Andriulli A

Published Mar 2021, in the Digestive and liver disease

The Role of Citrullination in Inflammatory Bowel Disease: A Neglected Player in Triggering Inflammation and Fibrosis?

Gabriele Dragoni, Gert De Hertogh, Séverine Vermeire

Published Jan 2021, in the Journal of Inflammatory bowel diseases

The ileoanal pouch: the next frontier in inflammatory bowel disease

Segal JP, Kayal M, Kochhar G, Dubinsky MC, Silverberg M, Shen B

Published Mar 2021, in the lancet. Gastroenterology & hepatology

Nutrition in the Management of Inflammatory Bowel Diseases

Sasson AN, Ingram RJM, Raman M, Ananthakrishnan AN

Published Mar 2021, in the Gastroenterology clinics of North America

Immunosuppressive Therapy and Risk of COVID-19 Infection in Patients With Inflammatory Bowel Diseases

Burke KE, Kochar B, Allegretti JR, Winter RW, Lochhead P, Khalili H, Colizzo FP, Hamilton MJ, Chan WW, Ananthakrishnan AN

Published Jan 2021, in the Journal of Inflammatory bowel diseases